{{Chembox
| ImageFile = Difenamizole.svg
| ImageSize = 200px
| ImageAlt = 
| IUPACName = 2-(Dimethylamino)-''N''-(2,5-diphenylpyrazol-3-yl)propanamide
| OtherNames = Diphenamizole
|Section1={{Chembox Identifiers
| CASNo = 
| PubChem = 65695
| ChemSpiderID = 59123
| ChEMBL = 2105587
| InChI=1S/C20H22N4O/c1-15(23(2)3)20(25)21-19-14-18(16-10-6-4-7-11-16)22-24(19)17-12-8-5-9-13-17/h4-15H,1-3H3,(H,21,25)
| InChIKey= PCXMKBOWWVXEDT-UHFFFAOYSA-N
| SMILES = CC(C(=O)NC1=CC(=NN1C2=CC=CC=C2)C3=CC=CC=C3)N(C)C}}
|Section2={{Chembox Properties
| C=20 | H=22 | N=4 | O=1
| Appearance = 
| Density = 
| MeltingPt = 
| BoilingPt = 
| Solubility = }}
|Section3={{Chembox Hazards
| MainHazards = 
| FlashPt = 
| AutoignitionPt = }}
}}

'''Difenamizole''' ([[International Nonproprietary Name|INN]]) (brand name '''Pasalin'''; former developmental code name '''AP-14''') is a [[nonsteroidal anti-inflammatory drug]] (NSAID) and [[analgesic]] of the [[pyrazolone]] group related to [[metamizole]].<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA398|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=398–}}</ref> It has [[monoaminergic]] properties, including inhibition of [[monoamine oxidase]], augmentation of [[pargyline]]-induced elevation of [[striatum|striatal]] [[dopamine]] levels, inhibition of [[potassium ion|K<sup>+</sup>]]-induced striatal dopamine [[neurotransmitter|release]], and inhibition of the [[reuptake]] of [[dopamine]].<ref name="SecciBolasco2011">{{cite journal|last1=Secci|first1=D.|last2=Bolasco|first2=A.|last3=Chimenti|first3=P.|last4=Carradori|first4=S.|title=The State of the Art of Pyrazole Derivatives as Monoamine Oxidase Inhibitors and Antidepressant/Anticonvulsant Agents|journal=Current Medicinal Chemistry|volume=18|issue=33|year=2011|pages=5114–5144|issn=0929-8673|doi=10.2174/092986711797636090}}</ref><ref name="pmid6454942">{{cite journal | vauthors = Kameyama T, Nabeshima T, Yoshida N, Yamaguchi K | title = Neurochemical studies of an analgesic, 1,3-diphenyl-5-(2-dimethylaminopropionamide)-pyrazole [difenamizole] | journal = Res. Commun. Chem. Pathol. Pharmacol. | volume = 31 | issue = 1 | pages = 31–53 | year = 1981 | pmid = 6454942 | doi = | url = }}</ref><ref name="NABESHIMAYAMAGUCHI1978">{{cite journal|last1=NABESHIMA|first1=Toshitaka|last2=YAMAGUCHI|first2=Kazumasa|last3=KAMEYAMA|first3=Tsutomu|title=EFFECTS OF DIFENAMIZOLE ON CONTENT OF CATECHOLAMINES AND METABOLITES IN MOUSE BRAIN|journal=The Japanese Journal of Pharmacology|volume=28|issue=4|year=1978|pages=642–646|issn=0021-5198|doi=10.1254/jjp.28.642}}</ref>

==See also==
* [[Famprofazone]]
* [[Morazone]]

==References==
{{Reflist|2}}

{{Analgesics}}
{{Dopaminergics}}

[[Category:Analgesics]]
[[Category:Dopamine reuptake inhibitors]]
[[Category:Monoamine oxidase inhibitors]]
[[Category:Nonsteroidal anti-inflammatory drugs]]
[[Category:Pyrazoles]]


{{analgesic-stub}}